- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07758998
The Effect of Motivational Interviewing on Smoking Behavior Among Nursing Students
The Effect of Motivational Interviewing on Changing Smoking Behavior Among Nursing Students
Smoking is one of the leading preventable public health problems worldwide, particularly among young adults who are at increased risk of nicotine dependence. Nursing students represent an important target population because, as future health professionals, they are expected to play a significant role in tobacco control and smoking cessation counseling. The Transtheoretical Model (TTM) is one of the most widely used theoretical frameworks for promoting health behavior change. The aim of this study will be to determine the effect of Transtheoretical Model-based motivational interviewing on changing smoking behavior among nursing students.
This study will be planned as a single-group, quasi-experimental pretest-posttest intervention. Nursing students who smoke cigarettes and voluntarily agree to participate will be included in the study. At baseline, participants will complete a Demographic Information Form, the Fagerström Test for Nicotine Dependence, the Stages of Change questionnaire, the Self-Efficacy/Temptation Scale, the Processes of Change Scale, and the Decisional Balance Scale.
Participants will receive Transtheoretical Model-based educational sessions and motivational interviewing interventions focusing on the health effects of smoking, reasons for smoking, the benefits of smoking cessation, identification of social support resources, relapse prevention strategies, and successful smoking cessation experiences. The Stages of Change questionnaire will be administered before each motivational interviewing session, and all outcome measures will be reassessed during follow-up evaluations. The study is expected to provide evidence regarding the effectiveness of Transtheoretical Model-based motivational interviewing in reducing smoking behavior, decreasing nicotine dependence, promoting progression through the stages of change, improving self-efficacy, enhancing the use of behavioral change processes, and supporting smoking cessation among nursing students.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Sevim Meral Feratoğlu, MSc
- Número de telefone: +905346674614
- E-mail: sevimmeralf@outlook.com
Locais de estudo
-
-
Kırklareli
-
Kırklareli, Kırklareli, Turquia (Türkiye), 39100
- Kırklareli University Faculty of Health Sciences
-
Contato:
- Sevim Meral Feratoğlu, MSc
- Número de telefone: +905346674614
- E-mail: sevimmeralf@outlook.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Nursing students currently enrolled in the study setting.
- Aged 18 years or older.
- Current cigarette smokers.
- No self-reported health condition that would prevent participation in the intervention.
- Willing and able to provide informed consent and participate in the study.
Exclusion Criteria:
- Inability to complete all planned stages of the study.
- Withdrawal of consent or voluntary discontinuation from the study at any time.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Motivational Interviewing
Participants will receive a Transtheoretical Model-based motivational interviewing intervention designed to promote smoking behavior change and smoking cessation.
The intervention will consist of structured face-to-face motivational interviewing sessions delivered in groups, supported by educational content on the health effects of smoking, benefits of smoking cessation, behavior change strategies, social support, relapse prevention, and self-efficacy enhancement.
Outcomes will be evaluated using validated questionnaires administered at baseline and follow-up assessments.
|
Participants will receive a Transtheoretical Model-based motivational interviewing intervention to promote smoking behavior change and smoking cessation.
Face-to-face motivational interviewing sessions will be conducted by a researcher trained in motivational interviewing.
According to the intervention protocol, participants may receive between two and six sessions depending on their readiness to change, individual needs, and continued participation throughout the study.
The intervention will include counseling and education on smoking-related health risks, smoking cessation, motivation enhancement, self-efficacy, behavior change strategies, social support, and relapse prevention.
Participants' stage of change will be assessed before each session, and the intervention will be tailored accordingly.
Outcomes will be evaluated using validated instruments measuring smoking behavior, nicotine dependence, stages of change, self-efficacy, and behavior change processes.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Smoking Behavior
Prazo: Baseline, Mid-intervention Assessment (1 month), Post-intervention Assessment (2 months)
|
The primary outcome is the change in smoking behavior following the Transtheoretical Model-based motivational interviewing intervention.
Smoking behavior will be evaluated by the average number of cigarettes smoked per day and smoking cessation status.
|
Baseline, Mid-intervention Assessment (1 month), Post-intervention Assessment (2 months)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Nicotine Dependence
Prazo: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
Nicotine dependence will be assessed using the Fagerström Test for Nicotine Dependence (FTND).
The total score ranges from 0 to 10, with higher scores indicating a higher level of nicotine dependence.
|
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
|
Change in Processes of Change
Prazo: Baseline, Mid-intervention Assessment( 1 month later), Post-intervention Assessment (2 months later)
|
Behavioral change processes will be assessed using the Processes of Change Scale.
The total score ranges from 22 to 110, with higher scores indicating greater use of behavioral change processes related to smoking cessation.
|
Baseline, Mid-intervention Assessment( 1 month later), Post-intervention Assessment (2 months later)
|
|
Change in Self-Efficacy/Temptation for Smoking Cessation
Prazo: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
Self-efficacy related to smoking cessation will be assessed using the Self-Efficacy/Temptation Scale.
The scale consists of 8 items rated on a 5-point Likert scale, with a total score ranging from 8 to 40.
Higher scores indicate greater self-efficacy and greater confidence in the ability to refrain from smoking in situations that may trigger the urge to smoke.
|
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
|
Change in Decisional Balance
Prazo: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
Decisional balance related to smoking cessation will be assessed using the Decisional Balance Scale.
The scale consists of 12 items rated on a 5-point Likert scale, with a total score ranging from 12 to 60. Higher scores indicate greater perceived importance of the benefits and barriers of change and greater engagement in the decision-making process related to smoking cessation.
|
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- KLU-SMOKE-MI
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .